Insider Trading Roundup: Executives Buy at Relmada, PVH; Major Holders Sell Dell, Hagerty

Recent regulatory filings disclosed a series of significant stock transactions by corporate insiders, with executives at Relmada Therapeutics and PVH Corp. making substantial purchases. In contrast, major institutional holders and executives at Dell Technologies, Hagerty, and Natera sold off large positions, many of which occurred as the stocks traded near 52-week highs.

Notable Insider Purchases

Insider buying is often monitored by investors as a potential signal of management's confidence in a company's future prospects. Several executives made noteworthy open-market purchases according to filings disclosed Friday.

• Relmada Therapeutics (RLMD): CEO Sergio Traversa purchased 200,000 shares for a total of $828,000, and CFO Maged Shenouda acquired shares valued at $843,990.
• PVH Corp. (PVH): CEO Stefan Larsson acquired 14,179 shares for approximately $1 million. The purchase comes after the stock declined nearly 5% over the past week, according to the source report.
• Clipper Realty Inc. (CLPR): Director and 10% owner Sam Levinson purchased stock totaling $388,130.
• Gloo Holdings, Inc. (GLOO): Executive Chair Patrick Gelsinger bought 50,000 shares for $166,875 as the stock traded near its 52-week low.

Significant Insider Sales

On the sell side, several large transactions were executed, with some taking place under pre-arranged trading plans. These sales coincided with strong stock performance for the respective companies.

Ad

• Hagerty, Inc. (HGTY): A 10% owner, Hagerty Holding Corp., sold 10,637,500 shares for total proceeds of approximately $122 million.
• Dell Technologies Inc. (DELL): Affiliates of major shareholder Silver Lake Partners sold Class C stock in separate transactions totaling over $55 million as the share price approached its 52-week high.
• Hinge Health, Inc. (HNGE): CEO Daniel Antonio Perez sold shares worth approximately $22.3 million. The transactions were conducted under a Rule 10b5-1 trading plan adopted in June 2026.
• Natera, Inc. (NTRA): Executive Chairman Matthew Rabinowitz sold 50,000 shares for nearly $16.4 million, also pursuant to a pre-arranged 10b5-1 plan.

What This Means for Investors

Insider transactions provide a window into the actions of a company's most informed individuals. While substantial buys can be a bullish indicator, insider sales are more nuanced. Insiders may sell shares for numerous reasons unrelated to the company's outlook, including portfolio diversification, tax planning, or personal liquidity needs.

The use of Rule 10b5-1 plans for the sales at Hinge Health and Natera is a key detail. These plans allow insiders to establish a pre-set schedule for selling stocks at a future date, providing an affirmative defense against potential accusations of trading on non-public information. Investors typically analyze insider activity in conjunction with other fundamental and technical data rather than as a standalone signal.